Deutsche Bank’s Enzymotec Ltd ENZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-101,587
| Closed | -$1.2M | – | 5824 |
|
|
2017
Q4 | $1.2M | Buy |
101,587
+75,900
| +295% | +$881K | ﹤0.01% | 3070 |
|
|
2017
Q3 | $294K | Buy |
+25,687
| New | +$253K | ﹤0.01% | 3686 |
|
|
2017
Q2 | – | Sell |
-6,721
| Closed | -$59K | – | 5281 |
|
|
2017
Q1 | $59K | Sell |
6,721
-15,661
| -70% | -$133K | ﹤0.01% | 4161 |
|
|
2016
Q4 | $146K | Sell |
22,382
-2,285
| -9% | -$15K | ﹤0.01% | 3862 |
|
|
2016
Q3 | $172K | Sell |
24,667
-4,717
| -16% | -$37.8K | ﹤0.01% | 3726 |
|
|
2016
Q2 | $245K | Buy |
29,384
+24,296
| +478% | +$201K | ﹤0.01% | 3667 |
|
|
2016
Q1 | $45K | Sell |
5,088
-5,058
| -50% | -$44.1K | ﹤0.01% | 4360 |
|
|
2015
Q4 | $99K | Sell |
10,146
-8,942
| -47% | -$84.7K | ﹤0.01% | 4059 |
|
|
2015
Q3 | $172K | Sell |
19,088
-1,532
| -7% | -$13.7K | ﹤0.01% | 3863 |
|
|
2015
Q2 | $172K | Buy |
20,620
+1,105
| +6% | +$10.1K | ﹤0.01% | 3962 |
|
|
2015
Q1 | $140K | Buy |
+19,515
| New | +$138K | ﹤0.01% | 3975 |
|
|
2014
Q3 | – | Sell |
-10,759
| Closed | -$145K | – | 6235 |
|
|
2014
Q2 | $145K | Sell |
10,759
-34,678
| -76% | -$582K | ﹤0.01% | 4342 |
|
|
2014
Q1 | $1M | Buy |
+45,437
| New | +$1.2M | ﹤0.01% | 2857 |
|
Deutsche Bank's ENZY Position: Q1 2018 in Review
Deutsche Bank sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 101,587 shares — an estimated $1.2M sold.
Deutsche Bank first reported a position in ENZY in Q1 2014 and held it in 13 quarters. The position peaked at $1.2M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.
- Deutsche Bank reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 101,587 Enzymotec Ltd shares in Q1 2018, an estimated $1.2M.
- Deutsche Bank first reported a position in Enzymotec Ltd in Q1 2014 and held it in 13 quarters.
- Deutsche Bank's Enzymotec Ltd position peaked at $1.2M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.